Cargando…
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Cancer is a disease of aging, and aged cancer patients have a poorer prognosis. This may be due to accumulated cellular damage, decreases in adaptive immunity, and chronic inflammation. However, the effects of the aged microenvironment on tumor progression have been largely unexplored. Since dermal...
Ejemplares similares
-
Autophagy- An emerging target for melanoma therapy
por: Ndoye, Abibatou, et al.
Publicado: (2016) -
In the Wnt-er of life: Wnt signalling in melanoma and ageing
por: Kaur, Amanpreet, et al.
Publicado: (2016) -
A glitch in the matrix: Age-dependent changes in the extracellular matrix facilitate common sites of metastasis
por: Marino, Gloria E., et al.
Publicado: (2020) -
Completing the Great Unfinished Symphony of Cancer Together: The Importance of Immigrants in Cancer Research
por: Morin, Pat J., et al.
Publicado: (2020) -
Co‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma
por: Echevarría‐Vargas, Ileabett M, et al.
Publicado: (2018)